ALOX15 Immunohistochemistry Aids in the Diagnosis of Eosinophilic Esophagitis on Pauci-eosinophilic Biopsies in Children

Abstract

Histologically, esophageal biopsies should have ≥15 intraepithelial eosinophils (IEEs) per high power field (HPF) to support a clinicopathologic diagnosis of eosinophilic esophagitis (EoE). Children with clinically apparent EoE may show pauci-eosinophilic biopsies due to patchy involvement. Immunostaining (Immunohistochemistry) for arachidonate-15 lipooxygenase (ALOX15) has been demonstrated to be a sensitive marker for EoE. We retrospectively assessed the expression of ALOX15 in 48 biopsies from 21 patients with established diagnosis of EoE and with tissue fragments below the threshold of 15 IEEs/HPF. Fragments were classified into pauci-eosinophilic and non-pauci-eosinophilic groups using cutoffs of 10 and 15 IEEs/HPF. Controls included patients with reflux and normal biopsies. Sixty-five (43.9%) fragments showed <10 IEEs/HPF and 83 (56.1%) showed ≥10 IEEs/HPF. Using a cutoff of 15 IEEs/HPF, 87 (58.7%) fragments showed <15 IEEs/HPF while 61 fragments (41.2%) had ≥15 IEEs/HPF. ALOX15 was positive in 53/65 (81.5%) of fragments with <10 IEEs/HPF versus 82/83 (98.8%) of fragments with ≥10 IEEs/HPF (P < .001). For a cutoff of 15 IEEs/HPF, 75/87 (86.2%) of pauci-eosinophilic fragments were ALOX15-positive, while 60/61(98.4%) of biopsies meeting the threshold were positive (P < .001). In 3/21 (14.3%) patients with EoE, all of the fragments (n = 7) were pauci-eosinophilic and all of them were positive for ALOX15. Two of 24 patients with reflux (one with 9 and one with 14 IEEs/HPF) were also positive. Fragments from normal controls (0 IEEs/HPF) were negative. Our results support the utility of ALOX15 immunohistochemistry in supporting the diagnosis of EoE in rare situations with strong clinical suspicion where no fragments reach 15 IEEs/HPF.

Keywords

eosinophilic esophagitis reflux ALOX15

Get full access to this article

View all access options for this article.

References

Molina-Infante

Ferrando-Lamana

Mateos-Rodriguez

Perez-Gallardo

Prieto-Bermejo

. Overlap of reflux and eosinophilic esophagitis in two patients requiring different therapies: a review of the literature. World J Gastroenterol 2008; 14(9): 1463–1466.

Liacouras

Furuta

Hirano

et al.

Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128(1): 3–20 e6. quiz 1–2.

Miehlke

. Clinical features of Eosinophilic esophagitis in children and adults. Best Pract Res Clin Gastroenterol 2015; 29(5): 739–748.

D’Alessandro

Esposito

Pesce

Cuomo

De Palma

Sarnelli

. Eosinophilic esophagitis: from pathophysiology to treatment. World J Gastrointest Pathophysiol 2015; 6(4): 150–158.

Gonsalves

. Distinct features in the clinical presentations of eosinophilic esophagitis in children and adults: is this the same disease? Dig Dis 2014; 32(1–2): 89–92.

Gonsalves

. Steroids versus dietary therapy for the treatment of eosinophilic esophagitis. Curr Opin Gastroenterol 2014; 30(4): 396–401.

Schoepfer

Gonsalves

Bussmann

et al.

Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation. Am J Gastroenterol 2010; 105(5): 1062–1070.

Muir

Merves

Liacouras

. Role of endoscopy in diagnosis and management of pediatric eosinophilic esophagitis. Gastrointest Endosc Clin N Am 2016; 26(1): 187–200.

Ravi

Talley

Smyrk

et al.

Low grade esophageal eosinophilia in adults: an unrecognized part of the spectrum of eosinophilic esophagitis?

Dig Dis Sci 2011; 56(7): 1981–1986.

10.

Jakarte

. Pauci-eosinophilic esophagitis: an under-recognized variant of eosinophilic esophagitis. Mod Pathol 2011; 24(15): 153A.

11.

Doyle

Odze

. Eosinophilic esophagitis without abundant eosinophils? The expanding spectrum of a disease that is difficult to define. Dig Dis Sci 2011; 56(7): 1923–1925.

12.

Ivanov

Kuhn

Heydeck

. Structural and functional biology of arachidonic acid 15-lipoxygenase-1 (ALOX15). Gene 2015; 573(1): 1–32.

13.

Matoso

Mukkada

et al.

Expression microarray analysis identifies novel epithelial-derived protein markers in eosinophilic esophagitis. Mod Pathol 2013(5); 26: 665–676.

14.

Matoso

Allen

Herzlinger

et al.

Correlation of ALOX15 expression with eosinophilic or reflux esophagitis in a cohort of pediatric patients with esophageal eosinophilia. Hum Pathol 2014; 45(6): 1205–1212.

15.

Liacouras

. Clinical presentation and treatment of pediatric patients with eosinophilic esophagitis. Gastroenterol Hepatol (N Y) 2011; 7(4): 264–267.

16.

Nielsen

Lager

Lewin

Rendon

Roberts

. The optimal number of biopsy fragments to establish a morphologic diagnosis of eosinophilic esophagitis. Am J Gastroenterol 2014; 109(4): 515–520.

17.

Lipka

Kumar

Richter

. Impact of diagnostic delay and other risk factors on eosinophilic esophagitis phenotype and esophageal diameter. J Clin Gastroenterol 2016; 50(2): 134–140.

18.

Schroeder

Robinson

Masterson

et al.

Esophageal human beta-defensin expression in eosinophilic esophagitis. Pediatr Res 2013; 73(5): 647–654.

19.

Safroneeva

Straumann

Coslovsky

et al.

Symptoms have modest accuracy in detecting endoscopic and histologic remission in adults with eosinophilic esophagitis. Gastroenterology 2016; 150(3): 581–590 e4.

20.

Molina-Infante

Prados-Manzano

Gonzalez-Cordero

. The role of proton pump inhibitor therapy in the management of eosinophilic esophagitis. Expert Rev Clin Immunol 2016; 12(9): 945–952.

21.

Jiao

Ishimura

Maruyama

et al.

Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients. J Gastroenterol 2016; 52(2): 203–210.

22.

Martin

Franciosi

Collins

et al.

Pediatric eosinophilic esophagitis symptom scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease. J Allergy Clin Immunol 2015; 135(6): 1519–1528 e8.